Hantavax injection

BIOLOGICAL2 trials

Sponsors

Green Cross Corporation

Conditions

HealthyInfection

Phase 3

Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS

CompletedNCT02360514

Green Cross CorporationInfection

Start: 2007-12-31End: 2012-10-31Updated: 2015-02-10

Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult

Green Cross CorporationHealthy

Start: 2015-11-30End: 2022-07-31Target: 317Updated: 2016-02-02

Related Papers

Immunogenicity and safety of a modified three-dose priming and booster schedule for the Hantaan virus vaccine (Hantavax): A multi-center phase III clinical trial in healthy adults.

2020-10-3111 citations